TNFSF13 and triple-negative breast carcinoma: In triple-negative breast cancer (TNBC), the upregulated TNFSF13 is found to be correlated with a poor response to chemotherapy, suggesting that TNFSF13 could be a predictive biomarker for patients receiving chemotherapy [59].